OPKO HEALTH, INC.
ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On February 19, 2021 , the Compensation Committee of the Board of Directors (the
"Committee") of OPKO Health, Inc. (the "Company") held a meeting to review
certain compensation matters for the Company's executive officers and
non-executive employees. At the meeting, the Committee: (i) granted stock
options to the Company's named executive officers to purchase the number of
shares of the Company's common stock set forth opposite their names below; (ii)
approved a cash bonus payment of $500,000 to Mr. Adam Logal , the Company's
Senior Vice President, Chief Financial Officer, Chief Accounting Officer and
Treasurer; and (iii) approved an annual salary increase for Mr. Logal from
$600,000 to $700,000 . The stock options vest ratably over four years, expire on
the tenth anniversary of the grant date, and have an exercise price of $4.81 per
share, which was the fair market value per share on the date of grant.
Name Title Stock Options
Phillip Frost Chief Executive Officer/Chairman 400,000
Jane H. Hsiao Vice Chairman/Chief Technical Officer 400,000
Steven D. Rubin Executive Vice President 350,000
Adam Logal Senior Vice President, Chief Financial Officer, Chief 350,000
Accounting Officer and Treasurer
ITEM 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
104 Cover Page Interactive Data File-the cover page XBRL tags are embedded
within the Inline XBRL document
--------------------------------------------------------------------------------
© Edgar Online, source
